BACKGROUND: Surgery and Anesthesia cause an excessive pro-inflammatory response. Mulago Hospital is faced with staff shortage making post-operative pain management difficult.Interleukin-6 (IL-6) drives inflammatory pain, endothelial cell dysfunction and fibrogenesis. Ketamine is cheap and, readily available. We hypothesized that its attenuation of serum IL-6 was a surrogate for clinical benefit. MATERIALS AND METHODS: Institutional Review Board's approval was sought and RCT was registered at clinical trials.gov (identifier number: NCT01339065). Consenting patients were randomized to receive pre-incision intravenous ketamine - 0.5mg/kg or 0.9% saline placebo in weighted dosing. Blood samples were collected and laboratory analyzed at baseline, post-operatively in PACU, 24 and 48 hours respectively. RESULTS: We recruited 39 patients of whom 18 were randomized to theketamine arm and 21 in the placebo arm with follow up at 24 and 48 hours. Serum IL-6and IL-1β levels were analyzed using ELIZA assay of pre-coated micro wells. Ketamine suppressed serum IL-6 at PACU with reduced increase at 24 hours. There was no reaction in 98% of IL-1β assayed. CONCLUSION:Low-dose ketamine attenuated early serum IL-6 levels due to surgical response with reduced 24 hour increase, but the difference was not statistically significant and we recommend more studies.
RCT Entities:
BACKGROUND: Surgery and Anesthesia cause an excessive pro-inflammatory response. Mulago Hospital is faced with staff shortage making post-operative pain management difficult.Interleukin-6 (IL-6) drives inflammatory pain, endothelial cell dysfunction and fibrogenesis. Ketamine is cheap and, readily available. We hypothesized that its attenuation of serum IL-6 was a surrogate for clinical benefit. MATERIALS AND METHODS: Institutional Review Board's approval was sought and RCT was registered at clinical trials.gov (identifier number: NCT01339065). Consenting patients were randomized to receive pre-incision intravenous ketamine - 0.5mg/kg or 0.9% saline placebo in weighted dosing. Blood samples were collected and laboratory analyzed at baseline, post-operatively in PACU, 24 and 48 hours respectively. RESULTS: We recruited 39 patients of whom 18 were randomized to the ketamine arm and 21 in the placebo arm with follow up at 24 and 48 hours. Serum IL-6 and IL-1β levels were analyzed using ELIZA assay of pre-coated micro wells. Ketamine suppressed serum IL-6 at PACU with reduced increase at 24 hours. There was no reaction in 98% of IL-1β assayed. CONCLUSION: Low-dose ketamine attenuated early serum IL-6 levels due to surgical response with reduced 24 hour increase, but the difference was not statistically significant and we recommend more studies.
Authors: M Antonelli; G Testa; L Tritapepe; R R D'Errico; D Costa; L Giovannelli; L Riccioni; A Gasparetto; G Catena Journal: J Cardiovasc Surg (Torino) Date: 1999-12 Impact factor: 1.888
Authors: J Börgermann; I Friedrich; S Flohé; J Spillner; M Majetschak; O Kuss; A Sablotzki; T Feldt; J C Reidemeister; F U Schade Journal: J Thorac Cardiovasc Surg Date: 2002-09 Impact factor: 5.209
Authors: L Roytblat; D Talmor; M Rachinsky; L Greemberg; A Pekar; A Appelbaum; G M Gurman; Y Shapira; A Duvdenani Journal: Anesth Analg Date: 1998-08 Impact factor: 5.108
Authors: R M Roumen; T Hendriks; J van der Ven-Jongekrijg; G A Nieuwenhuijzen; R W Sauerwein; J W van der Meer; R J Goris Journal: Ann Surg Date: 1993-12 Impact factor: 12.969
Authors: Alice Jacquens; Edward J Needham; Elisa R Zanier; Vincent Degos; Pierre Gressens; David Menon Journal: Int J Mol Sci Date: 2022-09-23 Impact factor: 6.208